Back to search

Switzerland· 65377004

Xigduo XR 10 mg / 500 mg, Filmtabletten

A metformin and dapagliflozin product containing metformini hydrochloridum, dapagliflozinum, registered in Switzerland by AstraZeneca AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A10BD15

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedXigduo XR 10 mg / 500 mg, Filmtablett…ATCA10BD15REGISTER NO.65377004PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Metformin and dapagliflozin is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BD15 (metformin and dapagliflozin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 8 of them publish a price we can compare per daily dose

Metformin and dapagliflozin · ATC A10BD15

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
metformini hydrochloridum, dapagliflozinum
Manufacturer
AstraZeneca AG
Country
Switzerland (CH)
ATC code
A10BD15
ATC class
Metformin and dapagliflozin
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680653770043
    98 Stk
    CHF 198.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for metformin and dapagliflozin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metformin and dapagliflozin · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and dapagliflozin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Dapagliflozin/Metformin Hcs, Dapagliflozin/Metformin Reddy
  • Bulgaria · Dapagliflozin/Metformin Tchaikapharma, Дапаглифлозин/Метформин Полфарма
  • Cyprus · Mexdagry
  • Czechia · Dapagliflozin/Metformin Polpharma, Mexdagry
  • Germany · Dapagliflozin/Metformin 089pharm, Dapagliflozin/Metformin 123 Acurae Pharma
  • Denmark · Dapagliflozin/Metformin Hydrochloride Juta, Dapagliflozin/Metformin Krka
  • Estonia · Mexdagry
  • Spain · Dapagliflozina/Metformina Aurovitas, Dapagliflozina/Metformina Krka
  • Finland · Dapagliflozin/Metformin Krka
  • France · Dapagliflozine/Chlorhydrate De Metformine Arrow, Dapagliflozine/Chlorhydrate De Metformine Krka
  • United Kingdom (Northern Ireland) · Dapagliflozin And Metformin Hydrochloride Milpharm, Dapagliflozin/Metformin Hydrochloride Torrent
  • Greece · Dapimefa, Mexdagry
  • Croatia · Dapagliflozin/Metforminklorid Krka, Dapagliflozin/Metforminklorid Krka D.D.
  • Hungary · Dapagliflozin/Metformin Pharmapath, Dapagliflozin/Metformin Polpharma
  • Ireland · Dapagliflozin/Metformin Krka
  • Iceland · Ebymect, Xigduo
  • Italy · Dapagliflozin E Metformina Aurobindo
  • Liechtenstein · Ebymect, Xigduo
  • Lithuania · Dapagliflozin/Metformin Polpharma, Mexdagry
  • Latvia · Dapagliflozin/Metformin Polpharma, Mexdagry
  • Malta · Dapagliflozin/Metformin Hydrochloride Aurobindo, Dapagliflozin/Metformin Hydrochloride Aurobindo Pharma
  • Netherlands · Dapaglozamet
  • Norway · Dapagliflozin/Metformin Krka, Ebymect
  • Poland · Diaflix Combo, Mexdagry
  • Portugal · Dapagliflozina + Metformina Farmoz, Dapagliflozina + Metformina Krka
  • Romania · Mexdagry
  • Sweden · Dapagliflozin/Metformin Elpen, Dapagliflozin/Metformin Krka
  • Slovenia · Mexdagry

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b9f0b6d0-2cd1-4949-93b9-e593b02959fe
GET /v1/drugs/b9f0b6d0-2cd1-4949-93b9-e593b02959fe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "metformini hydrochloridum 500 mg + dapagliflozinum 10 mg",
  "valid_from": "2016-06-01",
  "limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, wenn durch Diät und gesteigerte körperliche Aktivität keine ausreichende Kontrolle der Glykämie erreicht wird:<br>\\n- Für Patienten, welche mit den bisherigen oralen Therapien (Metformin und/oder Sulfonylharnstoffe) nur ungenügend eingestellt werden können oder diese nicht vertragen.<br>\\n- In Kombination mit einem DPP4-Inhibitor oder Insulin, wenn durch die maximal tolerierte Dosis an Metformin und einem DPP4-Inhibitor oder Insulin keine ausreichende glykämische Kontrolle erreicht wird.<br>\\n- In Kombination mit einem GLP-1-Analogon.<br>\\n- Für Patienten, die bereits mit einer freien Kombination von Dapagliflozin und Metformin als separate Tabletten behandelt werden.<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2026-02-01\"}]",
  "galenic_form": "Filmtabl 10 mg/500 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2016-06-01",
  "self_retention_pct": 10
}

See everything about metformin and dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.